We studied the regulation of in vivo expression of Escherichia coli glutaminyl-tRNA synthetase at the transcriptional and translational level by analysis of glnS mRNA and glutaminyl-tRNA synthetase levels under a variety of growth conditions. In addition, strains carrying fusions of the ,l-galactosidase structural gene and the glnS promoter were constructed and subsequently used for glnS regulatory studies. The level of glutaminyl-tRNA synthetase increases with the increasing growth rate, with a concomitant though much larger increase in ginS mRNA levels. Thus, transcriptional control appears to mediate metabolic regulation. It is known that glnR5, a regulatory mutation unlinked to ginS, causes overproduction of glutaminyl-tRNA synthetase. Here we showed that the glnR5 product enhances transcription of glnS 10-to 15-fold. The ginR5 mutation does not affect metabolic control. Thus, glnS appears to be regulated by two different control systems affecting transcription. Furthermore, our results suggest post-transcriptional regulation of glutaminyl-tRNA synthetase.
In Escherichia coli the regulation of aminoacyl-tRNA synthetases has been studied by both physiological (28) and genetic means (7, 26) and has been shown to be modulated in response to the growth rate of the cell. This phenomenon, termed metabolic regulation, has been shown to affect several components of the bacterial translation machinery, including RNAs (21, 27) , ribosomal proteins (11, 32) , elongation factors EF-Tu and EF-G (13) , and tRNA (34) . Of the twenty E. coli aminoacyl-tRNA synthetases, all thirteen that have been studied are metabolically regulated (6, 7, 16, 23, (28) (29) (30) . Recently it has been shown that this regulation of aminoacyl-tRNA synthetases is exerted at both the transcriptional and translational levels. In vitro transcription of alaS DNA is autogenously repressed by the binding of alanyltRNA synthetase to its structural gene (31) . Similarly, autogenous regulation of in vitro thrS expression is mediated by threonyl-tRNA synthetase (19) , but in this case regulation is at the translational level. Recent evidence from both in vitro (12) and in vivo (35) studies of phenylalanyl-tRNA synthetase expression indicates that pheS is regulated by phenylalanine-mediated attenuation control. It appears likely from these initial results that each synthetase is controlled by a unique regulatory mechanism. Identification of the level at which metabolic regulation of the other synthetases occurs awaits the study of the individual genes.
Mutants which cause alteration of the levels of individual aminoacyl-tRNA synthetases have been found both linked and unlinked to the structural gene of the enzyme. Presumed operator-promoter type regulatory mutations exist for many synthetases (1, 9, 18) . Regulatory mutations which are located at a distance from the structural gene of the synthetase they affect have been characterized for E. coli leucyltRNA synthetase (18, 36) and seryl-tRNA synthetase (36) . A similar mutation, glnR5, causes fivefold elevation in the levels of glutaminyl-tRNA synthetase (7) . glnR is located at min 25 on the E. coli chromosome and is unlinked to ginS (at min 14), the structural gene for glutaminyl-tRNA synthetase.
The mode by which these regulatory mutations alter synthetase expression is unknown.
In this paper we report that positive regulation of E. coli glutaminyl-tRNA synthetase occurs at the transcriptional level and that it is effected by the product of the unlinked gene glnR. There also appears to be posttranscriptional control of glutaminyl-tRNA synthetase biosynthesis.
MATERIALS AND METHODS
Growth media. Luria broth and M9 medium supplemented with the necessary nutrients have been described previously (25) Glutaminyl-tRNA synthetase measurement. Aminoacylation assays were as described previously (25) . Antibody titration assays were done by the method of LaRossa et al. (18) .
Nucleic acid preparation. Plasmid DNA preparation, the E. coli transformation procedure and restriction endonuclease digests were performed as described previously (22) . DNA fragments were 32P-labeled with [y-32P]ATP prepared by the method of Walseth and Johnson (37) . Isolation of RNA from E. coli was as described previously (15) .
DNA/RNA hybridization. The Si nuclease mapping technique (2) was used for the hybridization studies described in this paper. The glnS DNA fragment was a 298-base-pair-long DdeI-ClaI fragment covering the promoter and the 5'-terminal region of the gInS mature coding region (see Fig. 3A of reference 8). An excess of 32P-labeled ginS DNA was used to hybridize 0.1 mg of RNA isolated from the various cultures. The hybridization mixture was treated with Si nuclease. The Si-resistant 32P-labeled glnS DNA fragment was analyzed by electrophoresis on a 7 M urea-TBE-10% polyacrylamide gel. Hybridization conditions and S1 nuclease digestion conditions were as described by Hall and Yanofsky (16) . Although the DNA probe covers only the 5' portion of the ginS mRNA, we believe this DNA fragment to give a correct estimate of the mRNA.
The quantitation of mRNA was done by determining the amount of radiolabeled glnS DNA fragment protected by scanning different exposures of the autoradiograms. The lowest number obtained (e.g., the results from the acetate medium [see pGL2. Transcription of pGL2 initiates at the glnS promoter and translation starts at the glnS ATG codon and reads through into the ,-galactosidase structural gene. Plasmid pGL17 was derived from pAC27 which carries the 198 BglII glnS promoter fragment inserted into EcoRIHindIII-restricted pBR322 via EcoRI and HindIII linkers. The HindIII-BgiII fragment of the vector pMC903, described by Casadaban and Cohen (5) was inserted into HindlIl BamHI cut pAC2. Subsequently, the small HindIIIBamHI fragment, which contained a weak transcription termination site, was removed by HindIII-BamHI digestion, followed by blunt ending and ligation. The ligated DNA was introduced into MC1061, and Apr Lac' colonies were selected as described above. The DNA of one such transformant was analyzed and shown to have the structure of pGL17. Transcription of pGL17 initiates at the glnS promoter with translational read through into lacZ from the trpBA ribosome binding site.
The fidelity of both constructions was confirmed by DNA sequence analysis of the pGL2 gInS-lacZ junction and the pGL17 g1nS-trpBA-1acZ junction. In each case an appropriate restriction fragment spanning the junction was cloned into M13mp8, and the DNA sequence was determined by the dideoxy method (33) .
Insertion of a single copy of the glnS-lacZ fusions in the chromosome. To more closely mimic the in vivo situation, strains carrying a single copy of the glnS-lacZ fusions described above were constructed by homologous recombination between pGL2 or pGL17, respectively, and the chromosomal ,-galactosidase structural gene, using the rationale of Gutterson and Koshland (14) . Plasmids pGL2 and pGL17 were each introduced into strain p3478 by transformation with selection for Apr Lac' colonies on minimal plates containing ampicillin, glucose, and BCIG. Several Apr Lac' isolates were obtained for each transformation. In both cases, individual recombinants produced similar levels of P-galactosidase as indicated by the color intensity on the BCIG plates. However, the pGL17 recombinants expressed significantly higher levels of the enzyme than the corresponding pGL2 recombinants on BCIG plates. One pGL2 recombinant and one pGL17 recombinant were selected for subsequent experiments. To prevent segregation of the plasmid, the pGL2 polAl and pGL17 polAl strains were grown with the low-level ampicillin selection for all subsequent experiments.
,B-Galactosidase assays. P-Galactosidase was assayed by the method of Miller (24) on cultures grown in M9 minimal medium supplemented with thiamine, Casamino Acids, and glucose, glycerol, or acetate, respectively. Activities are expressed in the units (absorbance at 420 nm x 1,000/absorbance at 650 nm min/ml) described by Miller (24) .
RESULTS
Metabolic regulation of glutaminyl-tRNA synthetase. To achieve different growth rates, strains AB3441 (glnS+ glnR+), AB4143 (glnSI gInR+) and KL476 (glnSI glnR5) were grown in minimal medium with glucose, glycerol, or acetate as the sole carbon source. Two methods were used for quantitation of the glutaminyl-tRNA synthetase level. The enzyme activity in crude extracts from strains AB3441 and KL476 was assayed by the aminoacylation reaction. Antibody titration was used to measure the amount of enzyme in crude extracts of strain AB4143, as the thermolabile glutaminyl-tRNA synthetase in this strain does not exhibit enough aminoacylation activity to be assayed in vitro with the preparation methods used here. However, the thermolabile glutaminyltRNA synthetase can be assayed in strain KL476 owing to its fivefold overproduction caused by the glnR5 mutation. Our data from the aminoacylation assay show that the specific activity of the thermolabile ginSi enzyme is consistently 25% of that of the wild-type gInS+ enzyme (see also reference 7). In addition, the antibody titrations establish that the activity of glutaminyl-tRNA synthetase is directly proportional to its level in the cell. glnS mRNA was quantitated by determination of the amount of 32P-labeled ginS DNA fragment which hybridized to the total RNA obtained from 109 cells. This normalization of ginS mRNA levels to cell number is necessary because other RNAs and proteins (especially the ribosomal components) also vary with growth rate. Normal cellular fluctuations occur during metabolic changes. Therefore, we determined the RNA to protein ratio of the cells across the range of growth conditions to serve as an internal control.
Strain AB3441 (glnS+ glnR+). Figure 2A summarizes the results obtained using the wild-type strain. When the carbon source of the medium changed from acetate to glycerol to glucose, the growth rate of strain AB3441 increases from 0.4 to 0.8 and to 1.6 doublings per hour. Over this fourfold increase in growth rate, the specific activity glutaminyltRNA synthetase increases 2.1-fold. The ginS mRNA levels, as reflected by the levels of ginS DNA hybridized (Fig. 3A) , increase fivefold. Across the same range of growth rate, the RNA to protein ratio increases 1.75-fold from 0.29 to 0.5.
Strain AB4143 (ginSI glnR+). The results obtained from strain AB4143 are summarized in Fig. 2B . The growth rate of this strain increases from 0.3 to 0.6 and to 1.4 doublings per hour when the carbon source of the medium is acetate, glycerol, and glucose, respectively. Over this 4.6-fold increase in growth rate, the relative amounts of glutaminyltRNA synthetase increases 3.6-fold. The level of hybridized glnS DNA (Fig. 3B) again reflects a fivefold increase in glnS mRNA levels, and the RNA to protein ratio increases 2.25-fold.
Strain KL476 (ginSI glnR4). Results from strain KL476 are summarized in Fig. 2C . The growth rate increases from 0.3 to 0.9 and 1.4 doublings per hour in medium with acetate, glycerol, and glucose, respectively. Over this 4.6-fold increase in growth rate, the level of glutaminyl-tRNA synthetase increases by 1.9-fold. The levels of glnS DNA hybridized (Fig. 3C ) reflect an eightfold increase in the glnS mRNA level. Over the same range of growth rates, the ratio of RNA to protein increases 2.3-fold.
I(-Galactosidase assay of glnS-lacZ fusion strains. To check whether metabolic regulation at the transcriptional level can be dissected with the help of glnS-lacZ fusions we assayed P-galactosidase levels in our fusion strains grown in the same three media ( Table 2 ). The pGL17 glnS-lacZ fusion, which contains the ginS transcription signals and the trpBA ribosome binding site, has more elevated P-galactosidase levels at all growth rates than does the pGL2 fusion, which uses gInS transcriptional and translational signals. This result indicates that the trpBA ribosome binding site is used more efficiently than the corresponding ginS site. There is no evidence that the mechanism which effects growth rate-dependent expression of ginS is functioning on expression of P-galactosidase in the glnS-iacZ fusions. Indeed levels of P-galactosidase for the pGL2 glnS-IacZ fusion are lowest in the glucose-supplemented medium. The above results indicate that the glnS-iacZ fusions (i.e., the first 51 base pairs of the glnS structural gene) do not contain the DNA signals necessary to allow normal glnS metabolic control.
Regulation of ginS expression by glnR. glnS expression in strains AB3441, AB4143, and KL476 grown in Luria broth and M9-glucose media was compared at 37°C. The amount of glutaminyl-tRNA synthetase in these strains was determined by antibody titration and by aminoacylation assays. The results confirm earlier findings (8) on the levels of glutaminyl-tRNA synthetase in these strains. The amount of glutaminyl-tRNA synthetase is roughly the same for the ginS+ g1nR+ and ginSI glnR+ strains and is fivefold higher in gInSi ginRS strain (see Fig. 1 of reference 8) . Hybridization of 32P-labeled glnS DNA to 0.1 mg of RNA from each of these strains was performed. Since the three strains were grown in the same medium in this experiment, the amount of ginS DNA hybridized should correlate directly with the level of gInS mRNA in the fixed quantity of RNA used. The level of glnS mRNA is about 10 to 15 times higher in strain KL476 than in strains AB3441 and AB4143 when these strains are grown in Luria broth (Fig. 4) . The results of the experiments in minimal medium were similar (data not shown). Thus, ginR5 stimulates ginS transcription.
DISCUSSION
Transcriptional regul&ation is an element in metabolic control of ginS expression. The data on metabolic regulation of glutaminyl-tRNA synthetase in strains AB3441, AB4143, and KL476 are summarized in (23, 28, 30) , who showed that the level of glutaminyl-tRNA synthetase increases threefold over a two-to threefold increase in growth rate. Furthermore, their data show that the intracellular level of 11 aminoacyl-tRNA synthetases increases 1.5 to 4-fold over a 5-fold increase in growth rate, indicating that the metabolic regulation of E. coli aminoacyltRNA synthetases is a general phenomenon. Previously, Hall and Yanofsky (16) showed that metabolic regulation of E. coli tryptophanyl-tRNA synthetase is effected at the transcriptional level.
glnR5 is a positive regulator of glnS transcription. We have shown earlier that the gInR5 mutation increases fivefold the amount of glutaminyl-tRNA synthetase (7) . The results presented here show that the 5-fold overproduction of glutaminyl-tRNA synthetase caused by glnR5 is paralleled by a 10 to 15-fold increase in glnS mRNA, indicating that glnS is positively regulated on the transcriptional level by the unlinked gene glnR. This conclusion is supported by preliminary genetic studies which show that the introduction of one to two extra copies of glnR+ on an F' plasmid into strain AB4143 permits growth at the nonpermissive temperature, presumably due to increased expression of the thermolabile glutaminyl-tRNA synthetase (data not shown Posttranscriptional control of ginS expression. The results from the analysis of in vivo levels of gInS mRNA and glutaminyl-tRNA synthetase show that the transcriptional increase of glnS on metabolic upshift or as a consequence of the ginR5 mutation (Fig. 3) is not reflected by a proportional increase in the glutaminyl-tRNA synthetase level. Therefore some posttranscriptional control appears to regulate glutaminyl-tRNA synthetase expression. Our studies with the glnSlacZ fusions showed that the ginS ribosomal binding site is not used nearly as efficiently as that of trpBA (Table 2) .
Possibly transcription and translation from the glnS promoter are poorly coupled, resulting in inefficient use of the ginS ribosomal binding site. Alternatively, translation of the Results from our earlier ginS regulatory studies demonstrated that glnS transcription is not regulated by glutaminyl-tRNA synthetase, glutamine, tRNA01 , or glutaminyltRNAG0n (8) , but the effect of these molecules on translation of the glnS message has not been examined. Possibly the pGL2 glnS-lacZ fusion does not reflect transcriptional modulation due to the absence in this fusion of internal sequences of the glnS structural gene which are essential for physical regulatory interactions. Studies of glnS regulation in vitro in a coupled transcription-translation system should distinguish between these possibilities. One can speculate that elevated levels of glnS mRNA in the cell allow for rapid adjustments of glutaminyl-tRNA synthetase levels by more stringent modulation at the posttranscriptional level.
To examine in further detail the regulation of glnS expression, we are currently cloning the glnR and gnhRS genes to undertake molecular and functional characterization of the glnR product and its interaction with gInS.
